Immune Dysfunction in Allergic Asthma



Status:Completed
Conditions:Asthma
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 45
Updated:10/14/2017
Start Date:September 2005
End Date:June 2008

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Not a Drug Trial. We Are Using Anti-IgE to Examine the Role of Pulmonary Mast Cells in Asthma

We are using anti-IgE to investigate the role of pulmonary mast cells in asthma.

Subjects with mild allergic asthma are examined before, immediately after and 2 months after
a course of treatment with anti-IgE. The following are examined: Allergen skin tests,
allergen induced asthma, peripheral blood basophils, pulmonary bronchial mucosal mast cells.

Inclusion Criteria:

Mild asthma, adults -

Exclusion Criteria:

children. on inhaled or systemic steroids
We found this trial at
1
site
UNM HSC
2400 Tucker Avenue Northeast
Albuquerque, New Mexico 87131
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials